Additionally, SRPK1 and SRPK2 showed upregulated expression in CAC tissues compared with adjacent tissues, which is consistent with their expression patterns in acute myeloid leukemia, breast cancer, and pancreatic cancer [29–31]. Here, SRPK1 is linked to familial pancreatic carcinoma.